Pitoulias Georgios A, Valdivia Andrés Reyes, Hahtapornsawan Suteekhanit, Torsello Giovanni, Pitoulias Apostolos G, Austermann Martin, Gandarias Claudio, Donas Konstantinos P
Second Department of Surgery, Division of Vascular Surgery, Aristotle University of Thessaloniki, "G. Gennimatas" Hospital, Thessaloniki, Greece.
Department of Vascular and Endovascular Surgery, Ramón y Cajal's University Hospital, Madrid, Spain.
J Vasc Surg. 2017 Dec;66(6):1686-1695. doi: 10.1016/j.jvs.2017.03.440. Epub 2017 Jun 2.
Hostile proximal aortic neck (HN) challenges the suitability for standard endovascular aneurysm repair (EVAR) of patients at high risk for "open" repair. However, there has been little if any focus placed on the individual role of the "nonlength" HN features in EVAR outcomes. The aim of this study was to evaluate their individual and potentially predictive role in outcomes of EVAR under HN conditions.
Data of 156 consecutive EVAR patients with short (<15 mm) HN, treated with the Endurant device (Medtronic Cardiovascular, Santa Rosa, Calif) at three European academic vascular centers between 2007 and 2015, were collected and retrospectively analyzed. All patients had at least one of the four well-known nonlength HN criteria (width >32 mm or bulge, angulation >60 degrees, reverse taper anatomy, and circumferential thrombus or calcification >50%) and underwent standard EVAR without additional techniques, such as use of chimney grafts or endoanchors. Primary end points were absence of type IA endoleak at 1 month and midterm follow-up and aneurysm sac stabilization or shrinkage. Secondary end points were 30-day mortality, overall survival, and secondary interventions related to EVAR. The study cohort was classified in two subgroups related to neck length (length <10 mm and length between 10 and 14 mm) as well as in two subgroups according to on-label or off-label stent graft use.
Mean clinical and radiologic follow-up was 41.1 ± 24.7 and 31.7 ± 19.0 months, respectively. Overall EVAR-related mortality was 1.9% (n = 3). The total type IA endoleak rate was 5.8% (n = 9). In four patients, the type IA endoleak was detected intraoperatively and solved by endovascular means. A type IA endoleak was detected in three patients at 1 month and in two patients at 2-year follow-up. During follow-up, five patients showed an increase of aneurysm diameter due to type II endoleak and were treated by secondary endovascular reinterventions. The total number of all EVAR-related secondary procedures in the midterm was 12 (7.7%). Univariate analysis showed that the center of treatment and the clinical or anatomic features were not associated with adverse outcomes. Multiple regression and Cox regression analysis of HN features revealed that reverse taper anatomy (conical neck) was the single and significantly associated predictor of proximal EVAR failure (P < .012). Width >32 mm, angulation >60 degrees, and calcification or thrombus were not associated with adverse outcomes. Analysis between HN length cohorts and between on-label and off-label subgroups revealed no difference in outcomes.
A conical neck in hostile anatomies represents the single strongest factor associated with proximal failure of standard EVAR. This finding should be considered and highlighted apart from the length of the infrarenal neck to prevent midterm failure of standard EVAR.
对于“开放”修复手术风险高的患者,主动脉近端颈部不良(HN)会对标准血管腔内动脉瘤修复术(EVAR)的适用性构成挑战。然而,几乎没有关注过“非长度”HN特征在EVAR预后中的个体作用。本研究的目的是评估它们在HN情况下对EVAR预后的个体及潜在预测作用。
收集2007年至2015年间在三个欧洲学术血管中心接受Endurant装置(美敦力心血管公司,加利福尼亚州圣罗莎)治疗的156例连续的HN短(<15mm)的EVAR患者的数据,并进行回顾性分析。所有患者至少符合四项著名的非长度HN标准中的一项(宽度>32mm或膨出、成角>60度、逆向锥形解剖结构、圆周血栓或钙化>50%),并接受了标准的EVAR,未采用额外技术,如使用烟囱式移植物或腔内锚定装置。主要终点是术后1个月和中期随访时无IA型内漏以及动脉瘤囊稳定或缩小。次要终点是30天死亡率、总生存率以及与EVAR相关的二次干预。研究队列根据颈部长度(长度<10mm和长度在10至14mm之间)分为两个亚组,以及根据标签内或标签外支架型人工血管的使用情况分为两个亚组。
平均临床和影像学随访时间分别为41.1±24.7个月和31.7±19.0个月。总体EVAR相关死亡率为1.9%(n = 3)。IA型内漏总发生率为5.8%(n = 9)。4例患者术中检测到IA型内漏并通过血管腔内方法解决。3例患者在术后1个月检测到IA型内漏,2例患者在2年随访时检测到。随访期间,5例患者因II型内漏导致动脉瘤直径增大,并接受了二次血管腔内再干预治疗。中期所有与EVAR相关的二次手术总数为12例(7.7%)。单因素分析显示,治疗中心以及临床或解剖学特征与不良预后无关。对HN特征进行多元回归和Cox回归分析发现,逆向锥形解剖结构(锥形颈部)是近端EVAR失败的唯一且显著相关的预测因素(P <.012)。宽度>32mm、成角>60度以及钙化或血栓与不良预后无关。HN长度队列之间以及标签内和标签外亚组之间的预后分析未发现差异。
不良解剖结构中的锥形颈部是与标准EVAR近端失败相关的最强单一因素。除肾下颈部长度外,这一发现也应予以考虑和强调,以防止标准EVAR的中期失败。